Stem cell therapy for acute myocardial infarction-focusing on the comparison between Muse cells and mesenchymal stem cells

Rapid percutaneous coronary intervention for acute myocardial infarction (AMI) reduces acute mortality, but there is an urgent need for treatment of left ventricular dysfunction and remodeling after AMI to improve the prognosis. The myocardium …